Facebook
Twitter
LinkedIn
Forward
Youth with special healthcare needs are at increased risk for obesity and associated co-morbidities.
|
In this webinar, we will focus on deepening attendees understanding of the pathophysiology, diagnosis, and treatment of various comorbidities associated with childhood obesity. Dr.
|
Join us for an in-depth webinar designed for clinicians and scientists, exploring the intricate relationship between the gut microbiome and obesity.
|
In th
|
As psychedelics become increasingly decriminalized in various cities and countries, and excitement builds among scientists, physicians, and the general public, it is likely that more individuals wi
|
Join us for an informative session designed to enhance your expertise in prescribing GLP1 medications for the treatment of obesity.
|
The 2024 Obesity Medicine Association (OMA) Annual Business Meeting hosted by Lydia Alexander, MD, MFOMA, President of the OMA.
|
This session will provide a practical guide to understanding and interpreting continuous glucose monitoring (CGM) data for healthcare providers managing patients with diabetes and obesity.
|
Insulin resistance (IR) is a common biochemical abnormality in patients with excess adiposity, obesity, and its complications.
|
The number of non-nutritive sweeteners (NNS) available, both synthetic and natural, has increased rapidly in recent years.
|